1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Diabetes, Obesidad y Reproducción Humana

Diabetes, Obesidad y Reproducción Humana

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Nattero-Chávez L, Lorenzo M, Ruiz de Adana MS, Simó-Servat O, Abad M, Quirós C, Durán Martínez M, Quintero Tobar A, Bayona A, Ruiz Gracia T, De la Calle De la Villa E, Picón MJ.

    Prospective multicenter evaluation of glycemic and patient-reported outcomes following transition to a next-generation continuous glucose monitoring system in users of advanced hybrid closed-loop technology.

    Therapeutic Advances in Endocrinology and Metabolism . 17: .

    [doi:10.1177/20420188251407515]

  • Lobo R, Angulo A, Muñoz A, Colli E, Escobar-Morreale HF, Luque-Ramírez M, Zatik J, Regidor PA.

    Oral prolonged-release dienogest 2 mg and ethinylestradiol 0.02 mg in a 24/4-day regimen for polycystic ovary syndrome-associated hirsutism: a double-blind, randomised, placebo-controlled trial

    Eclinicalmedicine . 90: 103594-103594.

    [doi:10.1016/j.eclinm.2025.103594]

  • Luque-Ramírez M, Martínez-García MÁ, Insenser M, Quintero-Tobar A, de Lope Quiñones S, Nattero-Chávez L, Escobar-Morreale HF.

    Lipoprotein subclasses compensate the classic atherogenic lipid profile of women with polycystic ovary syndrome, but common antiandrogenic treatments worsen their lipidome

    EUROPEAN JOURNAL OF ENDOCRINOLOGY . 193(5): 595-605.

    [doi:10.1093/ejendo/lvaf213]

  • Quirós C, Wägner AM, Azriel S, Soldevila B, Beato-Vibora PI, Herrera Arranz M, Nattero L, Picón-César MJ, Climent E, Amigó J, Colomo N, Durán-Martínez M, Alpañes Buesa M, Megía A, Vinagre I, Vega Guedes B, Díaz-Soto G, Bandrés O, Barquiel B, López Tinocco C, Márquez-Pardo R, Martínez-Brocca MA, Corcoy R, Codina M, Piedra M, Rebollo Román Á, Cuesta M, López-Gallardo G, Goya Canino MM, Bugatto F, Mendoza LC, Olvera Márquez MDP, Perea V.

    A Real-World Study Comparing Advanced Hybrid Closed-Loop Systems During Pregnancy in Women with Type 1 Diabetes

    DIABETES TECHNOLOGY & THERAPEUTICS . : .

    [doi:10.1177/15209156251379488]

  • Luque-Ramírez M, Quintero-Tobar A, Martínez-García MÁ, de Lope Quiñones S, Insenser M, Nattero-Chávez L, Escobar-Morreale HF.

    Mild hyperprolactinemia in women with polycystic ovary syndrome. Insights from a large cross-sectional study

    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY . 41: 100412-100412.

    [doi:10.1016/j.jcte.2025.100412]

  • Gutiérrez CG, Vásquez MAS, Pascual-Corrales E, Berrocal VR, Luque-Ramírez M, Castro MA.

    Differences in clinical, hormonal and radiological profile between Cushing's disease and ectopic Cushing's syndrome. Series of 37 cases

    ANNALES D ENDOCRINOLOGIE . 86(5): 101802-101802.

    [doi:10.1016/j.ando.2025.101802]

  • Dokras, Anuja, Luque-Ramirez, Manuel, Escobar-Morreale, Hector F..

    POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Long-term health outcomes in polycystic ovary syndrome

    Reproduction . 170(2): . Nº de citas: 6

    [doi:10.1530/REP-25-0118]

  • Chico A, Pazos-Couselo M, Nattero-Chavez L, Simó-Servat O, Durán-Martínez M, Ugarte-Abasolo E, Aguilera E, Andía V, Moreno-Fernández J, Granados M, Rebollo A, Fernandez-Rubio E, Quirós C, Alpañés M, Márquez R, Beato-Vibora P, Lado-Baleato O, Picón-César MJ.

    Beyond glycemic metrics: Real-world benefits of connected insulin pens in type 1 diabetes

    DIABETES RESEARCH AND CLINICAL PRACTICE . 226: 112377-112377.

    [doi:10.1016/j.diabres.2025.112377]

  • Giralt M, Ferrer R, Díaz-Troyano N, Vega B, Luque-Ramírez M, Martínez S, Fernández B, Martínez I, Fabregat A, Urgell E, Cardona I, Casals G, Escobar-Morreale HF.

    Analytical Interference of Exemestane with Androstenedione Immunoassays

    ANNALS OF LABORATORY MEDICINE . 45(4): 410-419. Nº de citas: 1

    [doi:10.3343/alm.2024.0362]

  • Beato-Víbora PI, Chico A, Moreno-Fernandez J, Azriel-Mira S, Nattero-Chávez L, Mora RV, Alonso-Carril N, Simó-Servat O, Aguilera-Hurtado E, Reyes Céspedes LM, de Adana MR, Domínguez M, Márquez-Pardo R, Díaz-Soto G, Martínez-Brocca MA, Fernández KA, Buesa MA, Hernández MC, Quirós C.

    Transitioning between automated insulin delivery systems: A focus on personalisation

    DIABETES RESEARCH AND CLINICAL PRACTICE . 222: 112070-112070. Nº de citas: 4

    [doi:10.1016/j.diabres.2025.112070]

  • Bayona Cebada A, Nattero-Chávez L, De la Calle De la Villa E, Quintero Tobar A, de Lope Quiñones S, Dorado Avendaño B, Fiers T, Kaufman JM, Luque-Ramírez M, Escobar-Morreale HF.

    Androgen excess disorders remain undiagnosed in one of every four premenopausal women with Type 1 diabetes

    Human Reproduction Open . 2025(3): .

    [doi:10.1093/hropen/hoaf048]

  • de Lope Quiñones S, Luque-Ramírez M, Michael Fernández AC, Quintero Tobar A, Quiñones-Silva J, Martínez García MÁ, Insenser Nieto M, Dorado Avendaño B, Escobar-Morreale HF, Nattero-Chávez L.

    Unveiling Silent Atherosclerosis in Type 1 Diabetes: The Role of Glycoprotein and Lipoprotein Lipidomics, and Cardiac Autonomic Neuropathy

    Metabolites . 15(1): .

    [doi:10.3390/metabo15010055]

  • Nattero-Chávez L, de La Calle E, Lecumberri-Pascual E, Bayona Cebada A, Ruiz Gracia T, Quintero Tobar A, Lorenzo Moñino M, Sánchez Rodríguez C, Izquierdo A, Escobar-Morreale HF, Luque-Ramírez M.

    Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled clinical trial in patients with type 1 diabetes.

    Therapeutic Advances in Endocrinology and Metabolism . 15: .

    [doi:10.1177/20420188241288789]

  • Insenser MR, Nattero-Chávez L, Luque-Ramírez M, Quiñones SL, Quintero-Tobar A, Samino S, Amigó N, Dorado Avendaño B, Fiers T, Escobar-Morreale HF.

    Investigating the Link between Intermediate Metabolism, Sexual Dimorphism, and Cardiac Autonomic Dysfunction in Patients with Type 1 Diabetes.

    Metabolites . 14(8): .

    [doi:10.3390/metabo14080436]

  • Luque-Ramírez M, Martínez-García MÁ, Insenser M, Fernández-Durán E, Quintero-Tobar A, Fiers T, Kaufman JM, García-Cano AM, Rosillo Coronado M, Nattero-Chávez L, Escobar-Morreale HF.

    Influence of state-of-the-art laboratory techniques on the phenotyping of women with polycystic ovary syndrome in the clinical setting.

    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION . : .

    [doi:10.1007/s40618-024-02416-0]

  • Martínez-García MÁ, Quintero-Tobar A, de Lope Quiñones S, Insenser M, Fernández-Durán E, Escobar-Morreale HF, Luque-Ramírez M.

    Obesity and polycystic ovary syndrome influence on intestinal permeability at fasting, and modify the effect of diverse macronutrients on the gut barrier.

    FOOD RESEARCH INTERNATIONAL . 186: 114338-114338.

    [doi:10.1016/j.foodres.2024.114338]

  • Rodriguez-Muñoz A, Motahari-Rad H, Martin-Chaves L, Benitez-Porres J, Rodriguez-Capitan J, Gonzalez-Jimenez A, Insenser M, Tinahones FJ, Murri M.

    A Systematic Review of Proteomics in Obesity: Unpacking the Molecular Puzzle.

    Current obesity reports . 13(3): 403-438. Nº de citas: 1

    [doi:10.1007/s13679-024-00561-4]

  • Beato-Víbora PI, Chico A, Moreno-Fernandez J, Bellido-Castañeda V, Nattero-Chávez L, Picón-César MJ, Martínez-Brocca MA, Giménez-Álvarez M, Aguilera-Hurtado E, Climent-Biescas E, Azriel-Mira S, Rebollo-Román Á, Yoldi-Vergara C, Pazos-Couselo M, Alonso-Carril N, Quirós C.

    Response to Comment on Beato-Víbora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. Diabetes Care 2024;47:216-224.

    Diabetes Care . 47(5): 46-47.

    [doi:10.2337/dci24-0017]